5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.

Ka Chang

Managing Director

Zhe Chen

Managing Director

Peter Chen

Managing Director

Yu Cheng

Partner

Lu Huang

Director

Victor Jin

Managing Director

Jiangyun Jin

Managing Director

Ted Xutian Jing

Managing Director

Levi Liu

Partner

Qin Liu

Co-Founder, Investment Director and Board Member

Richard Liu

Founding Partner

Stephanie O'Brien

Investment Professional

Ken Shi

Founding Partner

Yi Sun

Senior Associate

Jerry Tong

Senior Associate

Yunhong Wei

Investor

Yaopeng Xing

Investor

Patricia Zhuoya Yang

Investor

Tony Yeung

Managing Director

Cloris You Youdan

Managing Director

Elwin Yuan

Partner

Yuan Ye

Partner

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

Past deals in Growth Stage

Evonetix

Series B in 2023
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, established in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. By employing novel techniques, Evonetix aims to synthesize DNA with higher accuracy and scale, which enhances accessibility for researchers. This platform enables scientists to utilize synthetic biology on a previously unattainable scale, fundamentally changing how DNA is accessed, produced, and utilized for gene synthesis. The engineering team at Evonetix boasts extensive experience in creating high-integrity automated systems, bringing together a diverse range of expertise from various scientific and engineering disciplines to support its mission.

LANDBASE

Series B in 2022
LANDBASE is a food brand management company driven by the concept of innovation & fashion. Committed to integrating global R&D and production resources, LANDBASE utilizes frontier food processing technologies to redefine traditional foods and build fashionable foods for the future.

Airspace Link

Series B in 2022
Airspace Link, Inc. is a company that specializes in managing local airspace for drones through its enterprise software-as-a-service platform. Founded in 2018 and based in Plymouth, Michigan, the company offers a range of tools designed for various stakeholders. Its AirRegistry platform facilitates the approval of automated drone package deliveries, while AirInspect provides tools for inspecting and approving registered drone delivery sites. AirHub aids in the creation of a comprehensive drone delivery network by mapping flight corridors, no-fly zones, and delivery locations. Additionally, AirLink enables state and local governments to share their regulated airspace with drone delivery services. By digitizing local airspace, Airspace Link supports safe recreational and commercial drone operations, fostering innovation and empowerment among businesses and citizens.

XYZ Robotics

Series B in 2022
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

VisionNav Robotics

Series C in 2022
VisionNav Robotics Limited designs, develops, and manufactures industrial vehicle vision driverless navigation equipment for indoor and outdoor scenes. Its products include vision navigation tray unmanned forklift, visual navigation balance heavy unmanned forklift, vision navigation forward-moving unmanned forklift, visual navigation unmanned tractor, and industrial vehicle driverless system solution. The company serves to e-commerce logistics, aviation logistics, third party logistics, retail fast moving goods, and home appliance sectors. The company was founded in 2015 and is based in Shenzhen, China.

Metis Pharmaceuticals

Series B in 2022
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Eko Health

Series C in 2022
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Casana

Series B in 2022
Casana is a healthcare technology company focused on heart health monitoring. It has developed the Heart Seat, an innovative product that integrates a toilet seat with a cardiovascular monitoring system. This device allows patients to conveniently track essential heart health metrics such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation from the comfort of their homes. The Heart Seat operates on a cloud-connected platform, enabling seamless data capture and analysis. Founded in 2018 and based in Rochester, New York, Casana aims to enhance heart health monitoring by providing a user-friendly solution that minimizes the need for active patient engagement.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

Virtue Diagnostics

Series B in 2022
Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.

Parametrix.ai

Series B in 2022
Developer of AI technology to revolutionize game development. The company utilizes AI technology to aid in complex environmental sensing within games, game playing/decision making, creating modeling teams and enemies, and developing player survival/evolution scenarios.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies specializes in the development of semiconductor chips tailored for computer vision, video processing, and various artificial intelligence applications. The company's innovative products are engineered to enhance the computing capabilities of AI visual applications, allowing manufacturers of computer devices to integrate advanced chip technology into their offerings. By focusing on optimizing performance in these specific areas, Vastai Technologies aims to support the growing demand for efficient and powerful AI solutions in the market.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Ieso

Series B in 2021
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Generate:Biomedicines

Series B in 2021
Generate Biomedicines, Inc. specializes in developing a generative biology platform aimed at inventing novel therapeutic proteins, including antibodies, peptides, enzymes, and other related compounds. Utilizing advanced machine learning techniques, the platform analyzes the genetic code that determines protein function, allowing for the creation of new protein sequences optimized for therapeutic applications. This innovative approach enables the company to generate proteins that interact specifically and effectively with targeted therapeutic needs, facilitating the development of new drugs across various protein modalities. Founded in 2018 and located in Cambridge, Massachusetts, Generate Biomedicines was previously known as Generate Biologics, Inc. until its name change in March 2020.

Geneoscopy

Series B in 2021
Geneoscopy, LLC is a diagnostic company based in Saint Louis, Missouri, focused on developing non-invasive solutions for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, Geneoscopy utilizes stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel aimed at identifying colorectal cancer by detecting the effects of cancer-related DNA mutations. The company is committed to improving colorectal cancer screening compliance and facilitating early detection, thereby reducing the associated morbidity and mortality. By employing a novel methodology to extract human RNA transcripts from stool samples, Geneoscopy aims to provide a reliable alternative to traditional colonoscopies, which are often viewed as unpleasant and invasive. In addition to its colorectal cancer diagnostic test, Geneoscopy is also exploring other potential applications of its RNA technology for additional gastrointestinal conditions.

Block Renovation

Series C in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

Moody

Series C in 2021
Moody is a developer of disposable colored contact lenses brand. The company's products are well branded and packaged, as well as hygienic for users, enabling consumers to purchase quality color contact lens products.

Axbio

Series B in 2021
Axbio Inc. is a biotechnology company based in Shenzhen, China, specializing in the development and manufacturing of advanced genetic sequencing technology and diagnostic equipment. Founded in 2016, the company offers a variety of genome extraction kits, including those for stool, blood, saliva, and bacteria. Axbio's product line also encompasses sequencing and diagnostic systems, disposable biochips, and reagents. The company employs semiconductor nanotechnology in its biochips for rapid molecular in-vitro diagnostics and utilizes a microfluidic Bio-CMOS platform for high-throughput sequencing. Axbio's capabilities extend from low-cost handheld devices for bedside diagnostics to fully automated instruments suitable for independent laboratories and hospitals, facilitating services such as early cancer screening, rapid pathogen detection, and drug development. The company is currently operating in stealth mode.

Exo Therapeutics

Series B in 2021
Exo Therapeutics, Inc. is a molecule drug discovery and development company to address intractable pharmaceutical targets. The company develops a pipeline of drug candidates that bind exosites, distal, and unique binding pockets that reprogram enzyme activity for therapeutic effect in oncology, inflammation. Exo Therapeutics, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

HOMEE

Series B in 2021
HOMEE, Inc. is a mobile application company based in Tampa, Florida, that connects homeowners, renters, and property managers with various service providers for home maintenance and improvement needs. Founded in 2016, the platform allows users to easily find and hire local professionals, including handymen, plumbers, electricians, and HVAC specialists, through a GPS-driven interface. The technology streamlines the process of accessing essential services and aims to enhance the overall experience for users by facilitating quick and efficient home service transactions.

Hai Robotics

Series C in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Alamar Biosciences

Series B in 2021
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

Etern

Series B in 2021
Etern is developing small molecule innovative drugs for oncology therapies.

Bota Biosciences

Series B in 2021
Bota Biosciences designs and develops synthetic bioengineering technology platform for bio-manufacturing. The company develops cloud databases and intelligent control software suitable for biotechnology development and production. Bota Biosciences was founded in 2019 and is based in Hangzhou, China.

Medrhythms

Series B in 2021
MedRhythms Inc. is a neuro-rehabilitation company that specializes in neurologic music therapy, utilizing sensors, music, and artificial intelligence to enhance therapeutic outcomes. Founded in 2015 and headquartered in Portland, Maine, the company focuses on patients affected by conditions such as traumatic brain injury, stroke, Parkinson’s disease, and Huntington’s disease. MedRhythms develops evidence-based interventions aimed at improving walking, speech, cognitive abilities, and overall functional outcomes through the intersection of music and neuroscience. By employing innovative technology and direct brain stimulation techniques, the company aims to provide effective rehabilitation solutions that leverage the therapeutic benefits of music for neurological recovery.

XYZ Robotics

Series B in 2021
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Amylyx

Series C in 2021
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

Block Renovation

Series B in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

Linus Health

Series B in 2021
Linus Health is a medical company that concentrates on brain and mental health by using digital technology.

ONES

Series B in 2021
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Triastek

Series B in 2021
Triastek Co. Ltd., founded in 2015 and based in Nanjing, China, specializes in the manufacture of 3D printed pharmaceuticals and related medical equipment. The company offers a range of products, including blockbuster and orphan drugs, as well as complex drug delivery technologies. Triastek develops proprietary 3D printing technology that encompasses the entire process from drug formulation design to continuous production. Its Melt Extrusion Deposition (MED) technology is applicable to solid formulations, enabling innovative drug delivery and development solutions. The company has also filed patent applications for its technologies, emphasizing its commitment to advancing pharmaceutical manufacturing through 3D printing.

Alentis Therapeutics

Series B in 2021
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is an online publisher specializing in blockchain and cryptocurrency data, offering a range of market and network analytics to various industries. Founded in 2017 and based in Cambridge, Massachusetts, the company provides several key products, including the CM Network Data Pro, which delivers historical crypto network data in a detailed format for institutional clients. Additionally, Coin Metrics offers the CM Market Data Feed, a standardized solution for trade, candle, and order book data from multiple exchanges, and CM Reference Rates, which provides fixed pricing for various assets quoted in U.S. dollars. By focusing on transparent and actionable data, Coin Metrics enables stakeholders to better understand and utilize public crypto networks.

Huoban

Series B in 2021
Developer of an internal collaborative platform designed to offer small and medium enterprises with sustainable development. The company's internal collaborative platform allows to promote cooperation between employees within the enterprise changes, enabling enterprises to get overall solution for development and operation.

Hai Robotics

Series B in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

SoupMaster

Series B in 2021
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.

Apnimed

Series B in 2021
Apnimed, Inc. is a clinical-stage company based in Cambridge, Massachusetts, focused on developing innovative pharmacologic therapies for sleep apnea and related disorders. Founded in 2017, the company aims to address the significant morbidity and mortality associated with sleep apnea, which affects over 20 million Americans. Apnimed's approach targets the neurobiological mechanisms that lead to airway obstruction, offering a simple, orally dosed treatment option. This strategy contrasts with current therapies, which primarily rely on positive pressure devices like CPAP, as well as other less commonly used methods such as mandibular advancement devices and surgical interventions. Apnimed's therapeutics are designed to alleviate both the physiological and symptomatic effects of obstructive sleep apnea, providing a safe and effective solution that addresses the underlying biology of the condition.

PhoreMost

Series B in 2021
PhoreMost Limited, a drug discovery company, engages in identifying new druggable targets for cancer and other unmet diseases. It develops Site-Seeker, a platform that systematically unmasks druggable sites in the human genome and links them to useful therapeutic functions in a live-cell context. The company was incorporated in 2014 and is based in Cambridge, United Kingdom.

Arctic Vision

Series B in 2021
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

Pony.ai

Series C in 2021
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

Liran cosmetics

Series B in 2021
Liran cosmetics operates as a men’s personal care brand. Liran cosmetics provides products catered to men covering skincare, body wash, hair care, body fragrance, and makeup, among others.

Shukun

Series C in 2020
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Horizon Robotics

Series C in 2020
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Curai

Series B in 2020
Curai is a virtual care company that leverages artificial intelligence to provide chat-based primary care services at reduced costs. Founded in 2017 by Neal Khosla and Xavier Amatriain, the company is headquartered in Palo Alto and aims to make high-quality, affordable primary care accessible globally. Curai's platform combines the expertise of clinicians with advanced AI technologies, facilitating a learning healthcare system that enhances the efficiency and effectiveness of care delivery. By helping patients communicate relevant information to medical professionals, Curai enables more accurate diagnoses and fosters improved patient outcomes. The service is available to individuals directly or through partnerships with enterprises.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gongsibao

Series B in 2020
Gongsibao, founded in 2014 and based in Chaoyang, China, operates an online-to-offline (O2O) enterprise service platform tailored for startups. The company's software-as-a-service (SaaS) platform offers a range of essential services, including company registration, taxation, intellectual property management, and various financial and legal assistance. By streamlining these processes, Gongsibao enables startups to establish and operate their businesses more efficiently and effectively.

GalaxySpace

Series C in 2020
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Zilliz

Series B in 2020
Zilliz is a technology company founded in 2017 and headquartered in San Francisco, California, with additional offices in China. It specializes in developing an intelligent data processing platform that enhances query performance, utilizing GPU hardware acceleration. Zilliz is renowned for its open-source project Milvus, which focuses on AI-powered unstructured data analysis and vector similarity search. Since its release in 2019, Milvus has gained significant traction, attracting over 400 enterprise users and engaging more than 120 contributors on GitHub. Its applications are diverse, encompassing areas such as image processing, computer vision, natural language processing, speech recognition, recommendation engines, and drug development. In 2020, Milvus became an incubation-stage project at the LF AI & Data Foundation, reflecting its active development and community support.

Pony.ai

Venture Round in 2020
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

Mockuai

Series C in 2020
Mockuai is a company positioned itself as an e-commerce Software-as-a-Service (SaaS) provider for key accounts.

InCarda Therapeutics

Series C in 2020
InCarda Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops transformative therapies for cardiovascular diseases that enable patients to use in the first moments of acute cardiovascular symptoms. The company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics, Inc. was formerly known as Pleiades Cardio-Therapeutics, Inc. and changed its name to InCarda Therapeutics, Inc. in May 2011. The company was founded in 2009 and is based in Newark, California.

Naxions

Series C in 2020
Beijing Naxions Technology Co., Ltd. is a healthcare-focused company that specializes in providing digital marketing services tailored for the pharmaceutical industry. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, Naxions has developed a software-as-a-service (SaaS) platform designed to enhance pharmaceutical sales management. The platform offers a range of services, including data capture, cleaning, and analysis, alongside features for content sharing and project management. By leveraging internet technology, Naxions aims to support pharmaceutical enterprises in developing their brand image and increasing market awareness through real-time data analysis and visualization.

XtalPi

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

XINGYUN GROUP

Series C in 2020
XINGYUN GROUP is a comprehensive services platform for global commodities in China, devoting to providing global channel operation, distribution, and supply chain services to brands, retailers, and international trade practitioners.

Revolo Biotherapeutics

Series B in 2020
Revolo Biotherapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and immunological diseases, such as asthma, atopic dermatitis, and inflammatory bowel disease. The company's approach is grounded in the natural mechanisms employed by Mycobacterium tuberculosis to evade the host immune system, allowing it to suppress inflammatory responses. Unlike existing treatments that aim to suppress the immune system and often require chronic dosing with significant side effects, Revolo's immune-resetting therapies have shown promise in preclinical and human studies by safely transitioning the immune system from a pro-inflammatory state to a regulatory one. This novel strategy aims to induce long-term disease remission without the adverse effects typically associated with conventional therapies. Founded in 2001 and based in London, Revolo Biotherapeutics is dedicated to transforming the treatment landscape for patients suffering from allergic and immune-mediated conditions.

LeLe Ketang

Series C in 2020
LeLe Ketang is an online K-12 education platform based in Beijing, China, founded in 2014. The company specializes in providing educational content and services, with a particular emphasis on primary school mathematics and language. Through its digital offerings, LeLe Ketang aims to enhance the learning experience for students in the K-12 segment, making quality education accessible and engaging.

Kuaidian Yuedu

Series C in 2020
Kuaidian Yuedu offers a story reading app.

Amylyx

Series B in 2020
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

Polaris Biology

Series B in 2020
Shanghai Polaris Biology Co., Ltd. is a medical technology company focused on developing a cell diagnostic technology platform for tumors. Established in 2016 and based in Shanghai, China, the company utilizes artificial intelligence-based cell analysis models to examine dynamic changes in tumors at the cellular level. This innovative approach aims to enhance clinical tumor diagnosis and treatment by providing precise and accurate diagnostic tools for both patients and healthcare professionals. Polaris Biology is dedicated to advancing the understanding of individual tumor characteristics, thereby supporting more effective clinical decision-making in cancer care.

Big Health

Series B in 2020
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

Sensors Data

Series C in 2020
Sensors was founded in 2015 by Sang Wenfeng, former technology manager at Baidu Inc's big data department. It currently provides big data analysis services for over 300 companies, including bike sharing company ofo, Chinese workout mobile app Keep, and video sharing and live streaming app Miaopai.

BooHee

Series C in 2020
Boohee provides you with tailor-made weight loss programs, simple and effective weight loss tools, supplemented by slimming courses, weight loss forums and food calorie enquiries, so that you are thin and healthy, thin and beautiful!

Evonetix

Series B in 2020
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, established in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. By employing novel techniques, Evonetix aims to synthesize DNA with higher accuracy and scale, which enhances accessibility for researchers. This platform enables scientists to utilize synthetic biology on a previously unattainable scale, fundamentally changing how DNA is accessed, produced, and utilized for gene synthesis. The engineering team at Evonetix boasts extensive experience in creating high-integrity automated systems, bringing together a diverse range of expertise from various scientific and engineering disciplines to support its mission.

ONES

Series B in 2019
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Xpeng Motors

Series C in 2019
XPeng Inc. designs, develops, manufactures, and markets smart electric vehicles in the People’s Republic of China and the United States. It offers SUVs under the G3 name; and four-door sports sedan under the P7 name. The company also provides vehicle leasing, bank loans, and auto insurance services. XPeng Inc. was founded in 2015 and is headquartered in Guangzhou, the People’s Republic of China.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

Inotrem

Series B in 2019
Inotrem S.A. is a biotechnology company based in Paris, France, specializing in the discovery and development of innovative treatments for inflammatory pathologies, particularly in critical care settings. Founded in 2013, the company focuses on immunotherapy and has created a novel immunomodulation approach targeting the TREM-1 pathway to manage excessive inflammation. Its lead product, nangibotide (also known as LR12), is a first-in-class TREM-1 inhibitor designed to address severe conditions such as septic shock and myocardial infarction. Inotrem is also advancing a program aimed at treating chronic inflammatory diseases, leveraging its proprietary technology platform to develop new therapeutic modalities.

Medannex

Series B in 2019
MedAnnex Limited is a biotechnology company based in Edinburgh, United Kingdom, focused on developing innovative treatments for patients with autoimmune diseases and cancers. Established in 2009, the company is known for its lead product, annexuzlimab, a monoclonal antibody designed to address various autoimmune conditions. MedAnnex aims to create first-in-class antibody therapies that significantly enhance the quality of life for individuals affected by these serious health issues. Through its research and development efforts, the company is committed to advancing therapeutic options in the biotechnology sector.

XtalPi

Series B in 2019
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

Zmjiudian

Series B in 2019
Zmjiudian is a startup company dedicated to the recommendation and reservation of surrounding resort hotels. It is dedicated to business travellers, leisure and holiday users to integrate suitable housing resources, and has a product weekend hotel app, which is a platform for hotel accommodation.

Zhuiyi

Series C in 2019
Zhuiyi Technology is an artificial intelligence company based in Shenzhen, China, specializing in deep learning and natural language processing. The firm develops AI solutions, including a chatbot named YiBot, designed to facilitate interactions between humans and enterprises. Its offerings encompass AI services for semantics, speech, and vision, enabling businesses to enhance customer service, conduct big data analysis, and deliver personalized services. Zhuiyi Technology's AI digital employee intelligence platform can be tailored for various business scenarios, supporting corporate and government functions in marketing, operations, and office tasks. The company serves a diverse range of industries, including finance, Internet, tourism, retail, real estate, and education, positioning itself as a key player in the field of enterprise intelligent services.

CollegeVine

Series B in 2019
CollegeVine is a company based in Cambridge, Massachusetts, founded in 2013, that specializes in providing comprehensive college admissions support. Originally known as Admissions Hero LLC, the company rebranded in August 2016. CollegeVine offers a range of services including mentorship, college application guidance, essay assistance, tutoring, and test preparation. Utilizing data-driven approaches, the company aims to facilitate the college admissions process for students and their families. Additionally, CollegeVine employs advanced artificial intelligence technology to enhance recruitment efforts for colleges and universities, leveraging proprietary data and an extensive network of high school students to streamline assistance in navigating the admissions landscape.

Horizon Robotics

Series B in 2019
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.

Shukun

Series B in 2019
Shukun (Beijing) Network Technology Co., Ltd. operates as an artificial intelligence based medical technology company. It offers CareSphere Advisor that includes CoronaryDoc, a coronary heart disease intelligent auxiliary diagnosis system; FFRDoc, an intelligent blood flow reserve fraction CT-FFR measurement system; CACScoreDoc for calculating calcification points; and AortaDoc, an aortic intelligent diagnosis system. The company was founded in 2017 and is based in Beijing, China with a branch in Shanghai.

Soul APP

Series C in 2018
SOUL is a social network that uses AI to help users find their soul mates.

Retrotope

Series C in 2018
Retrotope Inc. is a biotechnology company that focuses on developing drugs for the treatment of degenerative and intractable diseases, particularly neurological disorders. Based in Los Altos, California, the company aims to preserve and restore mitochondrial health through a novel drug platform that targets metabolic processes linked to oxidative stress. Retrotope's portfolio includes RT001, a drug designed for infantile neuroaxonal dystrophy, and it actively works on treatments for conditions such as Parkinson's disease, Alzheimer's disease, mitochondrial myopathies, and retinopathies. Established in 2006, Retrotope employs innovative approaches, including the isotope effect, to slow damaging biological pathways, thereby addressing various major classes of biopolymers and advancing its commitment to improving patient outcomes in degenerative diseases.

Hang

Series C in 2018
Agora, Inc. is a provider of Real-Time Engagement Platform-as-a-Service (RTE-PaaS) that enables developers to incorporate real-time video, voice, and messaging capabilities into their applications. Founded in 2013 and headquartered in Shanghai, the company offers a range of enterprise-grade products, including features for live interactive video and audio streaming, real-time messaging, and recording. Agora's solutions cater to various sectors such as social media, education, entertainment, gaming, healthcare, and financial services. The company operates a Software-Defined Real-Time Network, enhancing the delivery of its services across the globe. Additionally, Agora Lab, founded in 2014 and based in Palo Alto, California, focuses on developing real-time communication solutions, particularly in gaming and social networking. The Agora platform is recognized for its reliability and scalability, making it a widely adopted choice for organizations seeking efficient communication solutions.

Kuaidian Yuedu

Series B in 2018
Kuaidian Yuedu offers a story reading app.

Kuaidian Yuedu

Series B in 2018
Kuaidian Yuedu offers a story reading app.

Xgene Pharmaceutical

Series B in 2018
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.

ShareChat

Series C in 2018
ShareChat is an Indian social media startup. It offers the content consumption and sharing platform only in Indian vernacular languages to cater to over 1.17 billion wireless network users of India. It is available in 15 Indian languages. The company was founded in 2015 and is headquartered in Bangalore, Karnataka.

PingCAP

Series C in 2018
PingCAP, Inc., founded in 2015 and based in Beijing, China, develops TiDB, an open-source distributed Hybrid Transactional/Analytical Processing (HTAP) database. TiDB is designed to provide a comprehensive solution for both online transactional processing (OLTP) and online analytical processing (OLAP), offering infinite horizontal scalability, strong consistency, and high availability. The database is cloud-native and features SQL compatibility, allowing for seamless integration with existing systems. By focusing on open-source technology, PingCAP aims to provide a robust platform for users seeking efficient and stable database management for their online transactions and analytical needs.

BestSign

Series C in 2018
BestSign is a provider of electronic contract lifecycle services that aims to enhance transaction efficiency through the use of blockchain technology. Founded in 2017 and headquartered in Hangzhou, China, BestSign offers a platform that delivers reliable and user-friendly eSignature cloud services. These services encompass online signing, contract storage and management, as well as litigation support and insurance compensation. By leveraging the benefits of decentralization, BestSign enables enterprises across various sectors such as Internet finance, commercial real estate, online education, and e-commerce to improve their operational efficiency, reduce delivery costs, and implement effective digital contract management solutions.

Redcore Times

Series C in 2018
Redcore Times (Beijing) Technology Ltd. specializes in developing enterprise-level platforms that facilitate access to intranet resources from external networks. The company provides a range of products, including Redcore Mobile, which serves as an application portal for integrating enterprise applications while ensuring security and communication for users. Additionally, Redcore offers tools such as Redcore Browser, a software development kit for cloud applications, and Redcore Mobile Manager for enterprise mobility management. Its development platform, Redcore Studio, supports the entire mobile information construction process, from development to publishing. Other offerings include Xcloud, which converts web pages into HTML5 mobile applications, and Amaze UI, a mobile application development tool. Founded in 2012 and based in Beijing, Redcore was previously known as AllMobilize Inc. before rebranding in August 2018.

Thunder Stone Technology

Series B in 2018
Beijing ThunderStone Technology Co., Ltd. is the largest karaoke system supplier in China. It has 40% of the market share. China is one of the largest and matured karaoke markets in the world. A typical system consists of one or more VOD servers which based on Windows 2000 server edition and multiple STBs in karaoke rooms. They are all connected to the server or servers via Ethernet. The server is efficient and robust. A single server can support up to 60 DVD quality videos and audio streams.

Genedock

Series B in 2018
GeneDock, founded in September 2014, is a national high-tech enterprise specializing in precision medical data technology. The company develops and provides a comprehensive SaaS platform that allows users to extract, analyze, and visualize medical records, facilitating improved research and studies for medical and scientific institutions. With industry-leading expertise, GeneDock has successfully built data platforms for numerous prominent facilities, including top three hospitals and leading industry organizations in China. The core team comprises members with backgrounds from renowned companies, and the firm has attracted investment from notable institutions. GeneDock aims to drive innovation in healthcare through advanced data technology solutions.

Xpeng Motors

Series B in 2018
XPeng Inc. designs, develops, manufactures, and markets smart electric vehicles in the People’s Republic of China and the United States. It offers SUVs under the G3 name; and four-door sports sedan under the P7 name. The company also provides vehicle leasing, bank loans, and auto insurance services. XPeng Inc. was founded in 2015 and is headquartered in Guangzhou, the People’s Republic of China.

Cashify

Series C in 2018
Cashify is an online marketplace for reselling used electronic gadgets. It enables the customers to sell their old gadgets online and get instant cash and free home pick up. The company is headquartered in Gurgaon, Haryana, India.

Hang

Series B in 2018
Agora, Inc. is a provider of Real-Time Engagement Platform-as-a-Service (RTE-PaaS) that enables developers to incorporate real-time video, voice, and messaging capabilities into their applications. Founded in 2013 and headquartered in Shanghai, the company offers a range of enterprise-grade products, including features for live interactive video and audio streaming, real-time messaging, and recording. Agora's solutions cater to various sectors such as social media, education, entertainment, gaming, healthcare, and financial services. The company operates a Software-Defined Real-Time Network, enhancing the delivery of its services across the globe. Additionally, Agora Lab, founded in 2014 and based in Palo Alto, California, focuses on developing real-time communication solutions, particularly in gaming and social networking. The Agora platform is recognized for its reliability and scalability, making it a widely adopted choice for organizations seeking efficient communication solutions.

SenseTime

Series C in 2018
SenseTime is an artificial intelligence company based in Beijing, China, founded in 2014. It specializes in computer vision and deep learning technologies, offering a range of solutions including face and body analysis, image recognition, and video comprehension. The company develops advanced applications for various sectors, such as smart cities, intelligent automobiles, healthcare, finance, and education. Notably, SenseTime's face recognition technology is widely adopted, serving over 300 companies, including major players like China Mobile and Huawei, with an impressive accuracy rate of one error in 100,000. Additionally, SenseTime is engaged in research and development of AI technologies and provides AI software and hardware products across different industries. Its operations extend beyond China to offices in Japan and Singapore, reflecting its commitment to harnessing AI for diverse applications globally.

Sensors Data

Series C in 2018
Sensors was founded in 2015 by Sang Wenfeng, former technology manager at Baidu Inc's big data department. It currently provides big data analysis services for over 300 companies, including bike sharing company ofo, Chinese workout mobile app Keep, and video sharing and live streaming app Miaopai.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.